Securities Class Action Filed Against Alto Neuroscience, Inc.

Strategic Insights -

A national securities law firm, Faruqi & Faruqi, LLP, is investigating potential claims against Alto Neuroscience, Inc. ("Alto" or the "Company") (NYSE: ANRO) and reminding investors of the September 19, 2025 deadline to seek the role of lead plaintiff in a federal securities class action. The complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that Alto-100's clinical, regulatory, and commercial prospects were overstated due to its reduced effectiveness in treating Major Depressive Disorder (MDD).

Key Takeaways:

  • The complaint alleges that the Company and its executives made false and/or misleading statements about Alto-100's clinical, regulatory, and commercial prospects.
  • The Company issued a press release on October 22, 2024, announcing topline results from the Phase 2b trial evaluating Alto-100 as a treatment for MDD, which stated that Alto-100 did not meet its primary endpoint compared to placebo.
  • On this news, Alto's stock price fell $10.17 per share, or 69.99%, to close at $4.36 per share on October 23, 2024.
  • Analysts cut their price target for Alto after the announcement, with Jeffries reducing its price target to $17 from $33.
  • Faruqi & Faruqi, LLP is investigating potential claims against Alto Neuroscience, Inc. and reminding investors of the September 19, 2025 deadline to seek the role of lead plaintiff in a federal securities class action.

Statistics:

  • Alto's stock price fell 69.99% to close at $4.36 per share on October 23, 2024.
  • The price target for Alto was cut to $17 from $33 by Jeffries.
  • The deadline for investors to seek the role of lead plaintiff in a federal securities class action is September 19, 2025.

Sources:

  • Faruqi & Faruqi, LLP: "Investigation Regarding the Offer and Sale of Alto Neuroscience, Inc. Initial Public Offering"
  • PR Newswire: "Faruqi & Faruqi Encourages Investors Who Suffered Losses Exceeding $50,000 in Alto to Contact Partner Josh Wilson Directly to Discuss Their Legal Options"